News
-
-
-
-
COMMUNIQUÉ DE PRESSE
Viromed Medical AG: Annual General Meeting approves all proposed resolutions by a large majority
Viromed Medical AG's Annual General Meeting approves all proposed resolutions by a large majority. New Supervisory Board member elected, authorised capital replaced, and focus on innovation highlighted -
COMMUNIQUÉ DE PRESSE
Eckert & Ziegler Selected as US Manufacturer for Archeus’ Next-Generation Radiopharmaceutical ART-101
Eckert & Ziegler chosen as US manufacturer for Archeus' ART-101 radiopharmaceutical, targeting prostate cancer. Collaboration to support Phase 1 trial with state-of-the-art facility in Boston, MA -
-
COMMUNIQUÉ DE PRESSE
bioEnergy Development Inc. Announces First Sale of Breakthrough Mobile Bioreactor for On-Site Waste-to-Energy Conversion
bioEnergy Development Inc. sells first mobile bioreactor in Florida's equestrian industry, turning manure into energy and agricultural products, offering decentralized clean energy solutions -
-
-
COMMUNIQUÉ DE PRESSE
H&R GmbH & Co. KGaA: H&R Holding GmbH Waives Minimum Acceptance Threshold in Tender Offer to Shareholders of H&R GmbH & Co. KGaA
H&R Holding GmbH waives the minimum acceptance threshold in a tender offer to shareholders of H&R GmbH & Co. KGaA, providing increased transaction certainty. Shareholders can accept the offer until August 25, 2025
